“While studies certainly have limitations and may yet be confounded by other factors despite the best attempts to perform appropriate statistical adjustment, evidence of benefit is greatest for risks of type 2 diabetes, atrial fibrillation (the most common heart rhythm disturbance), heart attack, and stroke,”

Gregory Marcus · said 2026-07-20 · reported 2026-07-20

Marcus discussed the evidence of benefit for conditions including type 2 diabetes, atrial fibrillation, heart attack, and stroke.